Successful Efavirenz Dose Reduction in HIV Type 1-Infected Individuals with Cytochrome P450 2B6 *6 and *26Hiroyuki Gatanaga, Shinichi Oka, Tsunefusa Hayashida et al.|Clinical Infectious Diseases|2007Cited by 222